Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathophysiology of chronic rejection

P Häyry1

  • 1Transplantation Laboratory, University of Helsinki, Finland.

Transplantation Proceedings
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Chronic rejection involves ongoing injury to allograft blood vessels, leading to inflammation and arteriosclerosis. Targeting local inflammatory factors is key, as current treatments for acute rejection may indirectly help chronic rejection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol core needle biopsy and histological chronic allograft damage index as surrogate endpoint for Long-Term graft survival.

Transplantation proceedings·2004
Same author

Rational drug design: making drugs that make a difference.

Transplantation proceedings·2002
Same author

Quantitation of cell migration in a rat carotid artery balloon injury model. Indications for a perivascular origin of the neointimal cells.

Cardiovascular drugs and therapy·2002
Same author

Expression of estrogen receptor sub-types alpha and beta in acute and chronic cardiac allograft vasculopathy.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2001
Same author

Estrogen receptor beta dominates in baboon carotid after endothelial denudation injury.

Molecular and cellular endocrinology·2001
Same author

New targets for the prevention of transplant vascular disease.

Transplantation proceedings·2001

Area of Science:

  • Transplantation immunology
  • Vascular biology
  • Inflammatory cascades

Background:

  • Acute rejection involves T cell activation, while chronic rejection stems from persistent low-grade injury to allograft vascular endothelium.
  • Chronic rejection leads to allograft inflammation and arteriosclerosis through growth factor secretion and smooth muscle cell proliferation.
  • Distinct mechanisms necessitate different treatment strategies for acute versus chronic rejection.

Purpose of the Study:

  • To differentiate the mechanisms of acute and chronic allograft rejection.
  • To explore therapeutic strategies for managing chronic rejection.
  • To identify potential targets for improving long-term transplant survival.

Main Methods:

  • Review of current research on allograft rejection mechanisms.

Related Experiment Videos

  • Analysis of inflammatory cascades within allograft vascular walls.
  • Evaluation of existing and potential therapeutic interventions.

    • Main Results:

    • Chronic rejection is characterized by vascular endothelial injury and subsequent smooth muscle cell proliferation.
    • Interrelated inflammatory cascades within the vascular walls are central to chronic rejection.
    • No single therapy currently exists for chronic rejection prophylaxis or treatment.

    Conclusions:

    • Effective control of chronic rejection may involve regulating local cytokine, growth factor, and eicosanoid production.
    • Second-generation immunosuppressants like mycophenolate mofetil may reduce acute rejection episodes, a risk factor for chronic rejection.
    • Future treatments aim to significantly extend the half-life of renal transplants, improving long-term outcomes.